CEA (Carcinoembryonic Antigen) Rapid Test

CEA (Carcinoembryonic Antigen) Rapid Test

Rapid test for qualitative detection of Carcinoembryonic Antigen (CEA) in human serum or plasma to assist in monitoring certain cancers.

Tumor Markers Point-of-Care CF-04-04ACunder review

Key Features

Cancer biomarker detection
Tumor monitoring
Professional use
Point-of-care compatible
+1 more features

Product Overview

Rapid immunochromatographic assay for the qualitative detection of Carcinoembryonic Antigen (CEA) in human serum or plasma. Intended for professional in-vitro diagnostic use as an aid in monitoring colorectal cancer and other malignancies.

Product Features

Cancer biomarker detection
Tumor monitoring
Professional use
Point-of-care compatible
Rapid visual results

Applications

Clinical diagnostics
Point-of-care screening
Emergency diagnostics
Field testing

Specifications coming soon

Detailed technical parameters for this product are not published here yet. Contact us for the IFU, validation summary, or regulatory package.

Request specifications

Documentation & Resources

Download technical documentation, instructions for use, and certification documents.

No documents available

Documents for this product will be available soon.

Request Documentation

Ready to Order CEA (Carcinoembryonic Antigen) Rapid Test?

Contact our team to discuss your requirements, get pricing information, or find a distributor in your region.